Top in ID: First RSV vaccine; Walensky announces resignation

GSK’s Arexvy, a vaccine against respiratory syncytial virus, was approved by the FDA and is expected to be available this fall for adults aged 60 years and older.

It is the world’s first RSV vaccine to receive FDA approval, according to the agency. It was the top story in infectious disease last week.

Another top story was about the announcement that CDC Director Rochelle P. Walensky, MD, will resign at the end of June. A replacement has yet to be named.

Read these and more top stories in infectious disease below:

FDA approves first vaccine against RSV

The FDA approved the world’s first vaccine against respiratory syncytial virus, which followed years of failed attempts by scientists to develop one. Read more.

Walensky announces resignation as CDC director

Walensky announced Friday that she will resign as CDC director. Read more.

Stop antibiotics once incisions are closed, updated SSI guidance says

Antibiotics administered before and during surgery should be stopped immediately after the patient’s incision is closed, according to updated recommendations for preventing surgical site infections. Read more.

Nearly half of HCWs with COVID-19 worked despite symptoms

Nearly half of health care workers who tested positive for COVID-19 continued working at least part of 1 day with symptoms, according to a study published in Infection Control & Hospital Epidemiology. Read more.

WHO says COVID-19 no longer a global public health emergency

WHO said that the COVID-19 pandemic no longer constitutes a global public health emergency of international concern, citing reduced risks to human health driven by high population-level immunity and vaccination. Read more.